LPS-stimulated production of TNF-α by peripheral blood monocytes in patients with Behcet's Disease

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 764-767

  Slobodin, Gleb ^a   Toukan, Yazeed ^a   Rosner, Itzhak ^a   Rozenbaum, Michael ^a   Boulman, Nina ^a   Pavlotzky, Elsa ^a   Kessel, Aharon ^a   Toubi, Elias ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Behcet's disease; TNF

Indexed keywords

AZATHIOPRINE; CELL PROTEIN; COLCHICINE; CYCLOSPORIN; LIPOPOLYSACCHARIDE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHCET DISEASE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFORMED CONSENT; MALE; MONOCYTE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SELF CONCEPT; VOLUNTEER; WELLBEING;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34147104018     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0371-6     Document Type: Article

References (14)

1. Suzuki Kurokawa M, Suzuki N (2004) Behcet's disease. Clin Exp Med 4:10-20
2. Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C (2006) New approaches in the treatment of Adamantiades-Behcet's disease. Curr Opin Rheumatol 18:3-9
3. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediat Inflamm 11:87-93
4. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumor necrosis factor-alpha levels are increased in Bechet's disease. Clin Exp Dermatol 30:61-63
5. Bardak Y, Aridogan BC (2004) The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behcet's disease with ocular involvement. Ocul Immunol Inflamm 12:53-58
6. Duzgun N, Ayaslioglu E, Tutkak H, Aydintug OT (2005) Cytokine inhibitors: Soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Bechet's disease. Rheumatol Int 25:1-5
7. Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y (2003) Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine 24:210-218
8. Mege J-L, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor α, Interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544-1549
9. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin reagent. J Biol Chem 193:265-275
11. Imahara SD, O'Keefe GE (2004) Genetic determinants of the inflammatory response. Curr Opin Crit Care 10:318-324
12. Duymaz-Tozkir J, Gul A, Uyar FA, Ozbek U, Saruhan-Direskeneli G (2003) Tumour necrosis factor-alpha gene promoter region -308 and -376 G→ A polymorphisms in Behcet's disease. Clin Exp Rheumatol 21(4 Suppl 30):S15-S18
13. Colbert RA (2004) The immunobiology of HLA-B27: Variations on a theme. Curr Mol Med 4:21-30
14. Hamzaoui K, Hamza M, Ayed K (1990) Production of TNF-alpha and IL-1 in active Behcet's disease. J Rheumatol 17: 1428-1429